Glaxo Wellcome PLC.

PositionExecutive changes after merger - Brief Article

It's been called a merger of equals, but two former Glaxo Wellcome PLC execs didn't stick around to find out whether Glaxo's merger with SmithKline Beecham PLC would live up to its billing. A week after British drug giants merged to farm Glaxo SmithKline PLC, George Morrow -- former director of Glaxo's U.S. operations -- resigned as co-president of Glaxo SmithKline's U.S. operations to become California-based Amgen Inc.'s executive vice president for worldwide sales and marketing. The other co-president, David...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT